Defitelio defibrotide regulatory update

FDA approved an NDA from Jazz for Defitelio defibrotide to treat hepatic veno-occlusive disease (VOD) in patients with renal or pulmonary dysfunction after a hematopoietic stem cell transplant (HSCT)....